The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak
Tanyel Zübarioğlu, Duhan Hopurcuoğlu, Esma Uygur, Saffa Ahmadzada, Ece Öge Enver, Esra İşat, Mehmet Şerif Cansever, Ertuğrul Kıykım, Ayşe Çiğdem Aktuğlu Zeybek
Abstract
Introduction: The prognosis of phenylketonuria (PKU) in terms of neurocognitive outcome is directly related to lifelong phenylalanine (Phe) levels and adherence to treatment. Monitoring and treatment of PKU patients can be complicated in challenging circumstances as pandemics. This study aims to evaluate the impact of telemedicine for monitoring and treatment of PKU patients on metabolic outcome during coronavirus disease-19 (COVID-19) outbreak.
Topics & Concepts
MedicinePandemicOutbreakTelemedicinePhenylketonuriasPediatricsCoronavirus disease 2019 (COVID-19)DiseaseDried blood spotTetrahydrobiopterinInternal medicinePhenylalanineHealth careVirologyBiochemistryNitric oxideEconomicsBiologyEconomic growthInfectious disease (medical specialty)ChemistryAmino acidNitric oxide synthaseGeneticsMetabolism and Genetic DisordersDiet and metabolism studiesMitochondrial Function and Pathology